Skip to main content
. 2022 Nov 30;11(23):3841. doi: 10.3390/cells11233841

Figure 1.

Figure 1

The detailed workflow operating in this work to explore the clinical ICI treatment implications of RELN mutations based on the genomic data and immunotherapy information.